linsidomine has been researched along with thapsigargin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andre, A; Andriantsitohaina, R; Lagaud, GJ; Muller, B; Stoclet, JC | 1 |
| Boev, KK; Petkov, GV | 1 |
| Boev, KK; Petkov, GV; Spassov, GD | 1 |
| Brunet, A; Devynck, MA; Le Feuvre, C; Le Quan Sang, KH; Metzger, JP; Pham, TD; Vacheron, A | 1 |
| Graier, WF; Groschner, K; Malli, R; Schmidt, K; Thyagarajan, B | 1 |
| Bonilla, IM; Cardounel, AJ; Carnes, CA; Györke, S; Nishijima, Y; Sridhar, A | 1 |
6 other study(ies) available for linsidomine and thapsigargin
| Article | Year |
|---|---|
Effects of cGMP on calcium handling in ATP-stimulated rat resistance arteries.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium-Transporting ATPases; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Male; Mesenteric Arteries; Molsidomine; Myosins; Nitrendipine; Nitroprusside; Phosphorylation; Rats; Rats, Wistar; Terpenes; Thapsigargin; Vascular Resistance; Vasoconstriction | 1995 |
The role of sarcoplasmic reticulum and sarcoplasmic reticulum Ca2+-ATPase in the smooth muscle tone of the cat gastric fundus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Apamin; Calcium Channel Agonists; Calcium Channel Blockers; Calcium-Transporting ATPases; Cats; Cinnarizine; Enzyme Inhibitors; Gastric Fundus; In Vitro Techniques; Indoles; Male; Molsidomine; Muscle Contraction; Muscle, Smooth; Nifedipine; Nitroprusside; Potassium Channel Blockers; Sarcoplasmic Reticulum; Thapsigargin | 1996 |
Role of sarcoplasmic reticulum in the myorelaxant activity of nitric oxide donors in guinea pig gastric fundus.
Topics: Acetylcholine; Animals; Calcimycin; Calcium; Enzyme Inhibitors; Gastric Fundus; Guinea Pigs; Indoles; Ionophores; Male; Membrane Potentials; Molsidomine; Muscle Relaxation; Muscle Tonus; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Potassium Channel Blockers; Sarcoplasmic Reticulum; Sodium-Calcium Exchanger; Thapsigargin; Vasodilator Agents | 1998 |
Influence of SIN-1 on platelet Ca2+ handling in patients with suspected coronary artery disease: ex vivo and in vitro studies.
Topics: Angina Pectoris; Aspirin; Biological Transport; Blood Platelets; Calcium; Calcium Signaling; Catalase; Coronary Angiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Molsidomine; Nitric Oxide Donors; Platelet Aggregation Inhibitors; Superoxide Dismutase; Superoxides; Thapsigargin; Thrombin | 2000 |
Nitric oxide inhibits capacitative Ca2+ entry by suppression of mitochondrial Ca2+ handling.
Topics: Barium; Calcium; Cell Line; Cyclic GMP; Diethylamines; Dose-Response Relationship, Drug; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Oxadiazoles; Oxygen Consumption; Peroxynitrous Acid; Quinoxalines; Thapsigargin; Time Factors | 2002 |
Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology.
Topics: Action Potentials; Animals; Atrial Function; Dogs; Enzyme Inhibitors; Female; Male; Molsidomine; Myocytes, Cardiac; Nitric Oxide Donors; Thapsigargin; Ventricular Function | 2013 |